Nav: Home

Special Focus Issue of Therapeutic Delivery on the current status and opportunities for nanotechnolo

March 15, 2018

The Future Science Group (FSG) published journal, Therapeutic Delivery, today announced the release of its Special Focus Issue, which offers readers of the journal an insight into some of the recent developments, unanswered questions and future potential of nanotechnology in drug delivery.

This issue was guest edited by Rinti Banerjee (Indian Institute of technology Bombay, India) who stated in the issue's foreword: "A collection of articles including experimental papers, reviews and editorials have been invited from experts in the field to cover a wide range of subtopics of importance. These address emerging concepts and the recent advances in addressing important issues, allowing us to gain perspective on the current status and the future growth and success of the field." She continues: "It is hoped that this special issue will provide a glimpse into the multifaceted aspects of nanotechnology in drug delivery and emphasize the key aspects of this multidisciplinary field."

Highlights from the issue include a variety of review articles discussing a range of emerging platforms and their opportunities in this exciting field, including lipoprotein nanoparticles, and nanoscale biomachines such as micro- and nanomotors. In addition, the important issue of the translation of nanotechnology for clinical applications is also discussed.

Hannah Makin, Commissioning Editor for Therapeutic Delivery commented: "We are delighted to publish this Special Focus Issue, which aims to emphasise the importance and challenges facing this exciting field in drug delivery. We hope that this issue inspires researchers to contribute further to the successes in this multidisciplinary field and work towards overcoming the obstacles that stand in the way of the translation of nanotechnology-based drug delivery systems for clinical applications."
-end-
The full issue is available online here: https://www.future-science.com/toc/tde/9/4

Rinti's free-access foreword as guest editor is available online here: https://www.future-science.com/doi/full/10.4155/tde-2018-0014

About Therapeutic Delivery

The MEDLINE-indexed journal Therapeutic Delivery was launched in July 2010 as a monthly forum for reviews, original research, commentary and the latest industry developments in the field of drug delivery. In a highly competitive industry, Therapeutic Delivery provides the busy researcher with a forum for the rapid publication of original research and critical reviews of all the latest relevant and significant developments, and focuses on how the technological, pharmacological, clinical and physiological aspects come together to successfully deliver modern therapeutics to patients.

About Future Science Group

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.

Future Science Group

Related Nanotechnology Articles:

Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.
Want in on nanotechnology? Capitalize on collaborative environments
Patent law experts demonstrate that private-public partnerships lead to promising innovation output measured in patents.
Nanotechnology makes it possible for mice to see in infrared
Mice with vision enhanced by nanotechnology were able to see infrared light as well as visible light, reports a study published Feb.
Healing kidneys with nanotechnology
In new research appearing in the journal Nature Biomedical Engineering, Hao Yan and his colleagues at the University of Wisconsin-Madison and in China describe a new method for treating and preventing Acute Kidney Injury.
A treasure trove for nanotechnology experts
A team from EPFL and NCCR Marvel has identified more than 1,000 materials with a particularly interesting 2-D structure.
More Nanotechnology News and Nanotechnology Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...